LF
WST icon

Lansforsakringar Fondforvaltning’s West Pharmaceutical WST Stock Holding History

Lansforsakringar Fondforvaltning’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.26M Sell
22,998
-445
-2% -$136K 0.04% 341
2026
Q1 		$5.88M Sell
23,443
-779
-3% -$194K 0.03% 362
2025
Q4 		$6.66M Buy
24,222
+172
+0.7% +$47K 0.03% 352
2025
Q3 		$6.31M Buy
24,050
+362
+2% +$88K 0.03% 363
2025
Q2 		$5.18M Sell
23,688
-693
-3% -$148K 0.03% 385
2025
Q1 		$5.46M Buy
24,381
+131
+0.5% +$36.1K 0.03% 378
2024
Q4 		$7.94M Buy
+24,250
New +$7.63M 0.04% 317

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Lansforsakringar Fondforvaltning's WST Position: Q2 2026 in Review

Lansforsakringar Fondforvaltning reduced its West Pharmaceutical (WST) stake by 1.9% in Q2 2026, selling an estimated $136K and leaving 22,998 shares worth $8.26M. The position accounts for 0.04% of the portfolio, ranked #341.

Lansforsakringar Fondforvaltning first reported a position in WST in Q4 2024 and has held it in 7 quarters since. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Lansforsakringar Fondforvaltning held 22,998 shares of West Pharmaceutical worth $8.26M as of Q2 2026.
  • Lansforsakringar Fondforvaltning sold 445 West Pharmaceutical shares in Q2 2026, an estimated $136K.
  • West Pharmaceutical made up 0.04% of Lansforsakringar Fondforvaltning's portfolio in Q2 2026, its #341 holding.
  • Lansforsakringar Fondforvaltning first reported a position in West Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q2 2026, filed 13 Aug 2026.